跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,128 条关于
“NATiV3”
全部
1,128
临床试验
1,035
药物
8
机构
6
资讯
79
去年
Inventiva's Lanifibranor Maintains Positive Safety Profile in Phase 3 MASH Trial
去年
Inventiva's Lanifibranor Maintains Positive Safety Profile in Phase 3 MASH Trial
去年
Inventiva Secures €348 Million to Advance Phase 3 MASH Study of Lanifibranor
去年
Inventiva's Lanifibranor Phase III Trial NATiV3 Progresses in MASH/NASH Treatment
去年
Lanifibranor Shows Promise in Phase 3 MASH Trial with Improved Liver Health Biomarkers
去年
Inventiva Secures €21.4 Million to Advance Lanifibranor in MASH Phase III Trial
去年
Inventiva Appoints New Leadership Team to Advance MASH Drug Lanifibranor Through Phase 3 Trial
去年
Inventiva Receives $10 Million Milestone Payment from CTTQ for MASH Drug Development Partnership
3个月前
Claret Capital Partners Commits €43M to Inventiva's €130M Financing for Pivotal MASH Phase 3 Trial
去年
Inventiva Restructures to Focus on MASH Drug Development, Reports €96.6M Year-End Cash Position
第 1 页,共 8 页
上一页
下一页